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ASC filament formation serves as a signal
amplification mechanism for inflammasomes
Mathias S. Dick1, Lorenzo Sborgi2, Sebastian Ru¨hl1, Sebastian Hiller2 & Petr Broz1
A hallmark of inflammasome activation is the ASC speck, a micrometre-sized structure
formed by the inflammasome adaptor protein ASC (apoptosis-associated speck-like protein
containing a CARD), which consists of a pyrin domain (PYD) and a caspase recruitment
domain (CARD). Here we show that assembly of the ASC speck involves oligomerization of
ASCPYD into filaments and cross-linking of these filaments by ASCCARD. ASC mutants with a
non-functional CARD only assemble filaments but not specks, and moreover disrupt
endogenous specks in primary macrophages. Systematic site-directed mutagenesis of
ASCPYD is used to identify oligomerization-deficient ASC mutants and demonstrate that ASC
speck formation is required for efficient processing of IL-1b, but dispensable for gasdermin-D
cleavage and pyroptosis induction. Our results suggest that the oligomerization of ASC
creates a multitude of potential caspase-1 activation sites, thus serving as a signal amplifi-
cation mechanism for inflammasome-mediated cytokine production.
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D
etection of pathogens by the innate immune system relies
on germline-encoded pattern recognition receptors
(PRRs), which recognize a variety of pathogen-derived
molecules, known as pathogen-associated molecular patterns
(PAMPs), and host-derived danger signals, known as danger-
associated molecular patterns1. Although most PRRs initiate
transcriptional responses, such as the expression of cytokines2,3, a
subset of cytosolic PRRs promote the assembly of inflammasome
complexes and subsequent activation of the cysteine protease
caspase-1 (refs 4,5). To date, only members of the NOD-like
receptor (NLR) family, the PYHIN protein family and PYRIN
were shown to assemble inflammasomes in response to different
cytosolic PAMPs or danger-associated molecular patterns5,6.
A unifying feature of all these receptors is either a pyrin domain
(PYD) or a caspase recruitment domain (CARD), both of which
belong to the death-fold domain superfamily. On the basis of the
presence of these domains, the receptors can be classified as PYD-
containing receptors (NLRP3: NLR family, PYD containing 3;
AIM2: absent in myeloma 2; pyrin) or CARD-containing
receptors (NLRC4: NLR family, CARD containing 4; NLRP1:
NLR family, PYD containing 1). After receptor activation and
oligomerization, these domains recruit the adaptor protein ASC
(apoptosis-associated speck-like protein containing a CARD) and
pro-caspase-1 into the complex through homotypic domain–
domain interactions. Within the inflammasome, pro-caspase-1 is
activated by dimerization and auto-proteolysis, and the
proteolytically active hetero-tetramer is released7. Several
substrates of caspase-1 have been identified, among them
the pro-forms of the cytokines interleukin (IL)-1b and IL-18
(refs 7–9). Another consequence of inflammasome activation is
the induction of a pro-inflammatory cell death called
pyroptosis10. Pyroptosis is driven by the amino-terminal
cleavage fragment of gasdermin-D, a protein cleaved by
caspase-1, and results in the lysis of the host cell and
subsequent release of cytoplasmic content, among them
processed IL-1b and IL-18 (refs 11,12).
Recent studies have started to elucidate the role of the
inflammasome adaptor protein ASC13–15, a bipartite protein
composed of a PYD and a CARD, also known as PYCARD16,17.
ASC has previously been regarded as a simple adaptor protein
that links PYD-containing receptors to the CARD-containing
caspase-1, via homotypic PYD–PYD and CARD–CARD
interactions18. However, its role appears to be more complex,
as on receptor activation ASC also forms the so-called ASC speck,
a macromolecular form of the inflammasome with a diameter of
B1–2 mm19,20. Formation of the ASC speck is independent of
caspase-1 activity, but requires the oligomerization of ASC into
large insoluble aggregates20,21. These ASC aggregates are stable
and have even been shown to be released into the extracellular
space, after pyroptosis induction, where they can trigger
prolonged inflammasome activation in phagocytic cells22,23.
Analyses of stimulated emission depletion microscopy images
and electron micrographs suggest an irregular, filamentous
shape22,23. Consistently, we and others have shown that ASC
oligomerizes into long helical filaments via its PYD13–15. Despite
the advances regarding the atomic structure of the ASC filament,
whether the ASC speck is the functional unit of the
inflammasome is unclear. Several inflammasome receptors (for
example, NLRC4 and mouse Nlrp1b) contain a CARD instead of
a PYD and are able to recruit caspase-1 even in the absence of
ASC. Indeed, we and others have shown that ASC is not required
for cell death induction by these receptors24–28. Nonetheless,
activation of CARD-containing receptors results in ASC speck
formation in wild-type (WT) cells, but how their CARD initiates
ASC filaments is unknown. Furthermore, it is unclear whether
ASC oligomerization itself is required for inflammasome
signalling. Previous mutagenesis studies of ASC could not
address the role of ASC oligomerization in signalling, as they
were based on overexpression of ASC mutants in HEK293 cells,
which is prone to artefact generation and lacks the means to study
the effects on downstream signalling13,29,30.
Here we use retroviral expression of ASC mutants in
Asc-deficient immortalized mouse macrophages, to address the
mechanism of ASC speck formation and the functional relevance
of ASC filament formation for inflammasome signalling.
Our results reveal an architectural role for the ASCCARD, showing
that it is required to link individual ASC filaments towards
forming the dense ASC speck. Furthermore, we show that ASC
bridging molecules are necessary to allow CARD-containing
receptors the initiation of ASC filament formation. Finally, we use
site-directed mutagenesis of the ASCPYD–ASCPYD interaction
interfaces to identify mutations that disrupt ASC filament
formation without affecting the interaction to receptor PYDs.
Surprisingly, such ASC mutants are still able to initiate caspase-1-
dependent gasdermin-D maturation and subsequent cell death,
but lack the ability to form filaments, to assemble ASC specks and
to process IL-1b, thus uncoupling the two major downstream
signalling pathways. In conclusion, our data show that the ASC
speck has a function in inflammasome signalling and support a
model in which the rapid oligomerization of ASC via its PYD
creates a multitude of potential caspase-1 activation sites, thus
serving as a signal amplification mechanism for inflammasome
signalling.
Results
Distinct roles for the ASCPYD and ASCCARD in speck assembly.
Although ASC is the main structural component of the ASC
speck20,24, conflicting reports have implicated either the ASCPYD
or the ASCCARD in speck assembly13,31,32. To address the role of
the ASCPYD and the ASCCARD in speck formation and
downstream signalling, we transduced immortalized Asc /
murine bone marrow-derived macrophages (BMDMs) with
fluorescently tagged full-length ASC (ASCFL) or ASCPYD and
ASCCARD alone (Fig. 1a). As overexpression of ASCFL can result
in aggregation even in the absence of activated receptor19, we
selected individual clonal lines that did not display any
autoactivation when unstimulated (Supplementary Fig. 1a).
To test the functionality of these constructs, cells were primed
with lipopolysaccharide (LPS) and transfected with the synthetic
DNA analogue poly(deoxyadenylic-deoxythymidylic) acid
(poly(dA:dT)), an activator of AIM2 (refs 33,34). mCherry-
tagged ASCFL, expressed in Asc / cells, promoted pyroptosis
(as measured by the release of lactate dehydrogenase (LDH)) and
IL-1b release (measured by enzyme-linked immunosorbent assay
(ELISA)), to levels seen in immortalized WT macrophage
controls (Fig. 1b). We also observed comparable levels of IL-
1b/-18 and caspase-1 processing and release by western blotting
(Supplementary Fig. 1b). In contrast, neither the ASCPYD nor
ASCCARD restored cell death, IL-1b/-18 secretion or caspase-1
cleavage on AIM2 activation (Fig. 1b and Supplementary Fig. 1b).
Similarly, expression of the individual domains did not restore
inflammasome signalling in response to extracellular ATP,
an NLRP3 activator35 (Supplementary Fig. 1c,d).
Heterologous expression of ASCPYD and ASCCARD or CARDs
of mitochondrial antiviral-signalling protein (MAVS), retinoic
acid-inducible gene 1 (RIG-I) and pro-caspase-1 results in the
formation of filaments of varying length in different cell types and
in vitro13,36–40. However, it is possible that such ASCPYD or
ASCCARD filaments are overexpression artefacts, as ASCFL
normally forms a distinct dense speck structure20. To assess the
ability of ASCPYD and ASCCARD to form macromolecular
assemblies, we examined the above described cell lines by
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11929
2 NATURE COMMUNICATIONS | 7:11929 | DOI: 10.1038/ncomms11929 | www.nature.com/naturecommunications
microscopy, following inflammasome stimulation. As expected,
activation of AIM2 or NLRP3 induced the formation of
perinuclear specks in cells expressing mCherry-tagged ASCFL
(Fig. 1c and Supplementary Fig. 1e,f). In line with the reported
ability of ASC to form filaments13,15, specks formed by ASCFL
had a dense core with emanating filaments (Fig. 1c). Instead of
forming similarly dense specks, the ASCPYD assembled into
filaments on the engagement of NLRP3 or AIM2 (Fig. 1c). Of
note, filaments formed after NLRP3 or AIM2 activation differed
in their appearance, possibly due to distinct modes of how NLR
and PYHIN family members assemble complexes and initiate
ASC filaments13,41. Remarkably, these filaments had varying
lengths and widths, with some appearing clearly thicker than
90Å, the reported diameter of an ASCPYD filament13,15. Unlike
reported before, we observed that the ASCCARD was not able to
form macromolecular assemblies (Fig. 1c and Supplementary
Fig. 1e,f). Taken together, these data suggest that although
both domains of ASC are necessary for signalling, only the
ASCPYD forms filaments on inflammasome activation. This is
consistent with reports by us and others showing that full-length
ASC forms helical filaments in vitro via the ASCPYD (refs 13,15),
whereas the ASCCARD is exposed on the surface and not involved
in ASC filament formation15. As straight filaments are formed by
ASCPYD and compact specks are formed by ASCFL, our data also
suggest that the ASCCARD must contribute significantly to the
macroscopic structure of the ASC speck.
ASCCARDs condense ASCPYD filaments into ASC specks. To
test whether ASCCARD is required to form ASC specks, we gen-
erated immortalized Asc / macrophage lines expressing
ASCD130R or ASCD134R (Fig. 2a and Supplementary Fig. 2a), two
mutations in surface-exposed residues of the ASCCARD that
abrogate interaction of the ASCCARD with the pro-caspase-1CARD
(ref. 31). As expected, Asc / macrophages expressing
ASCD130R or ASCD134R did not activate caspase-1, release
mature IL-1b or undergo pyroptosis in response to DNA
transfection or ATP treatment (Fig. 2b and Supplementary
Fig. 2b–d). ASCD130R and ASCD134R formed long filaments rather
than dense ASC specks in response to AIM2
and NLRP3 activation (Fig. 2c,d and Supplementary Fig. 2e,f),
similar to the ASCPYD alone, thus supporting our hypothesis
that a functional ASCCARD is required to assemble ASCPYD
filaments into a speck. To confirm that these mutations not
only disrupt ASCCARD–pro-caspase-1CARD interactions but also
ASCCARD–ASCCARD interactions, we expressed enhanced green
fluorescent protein (eGFP)-tagged ASCCARD in the presence of
reconstituted inflammasomes, formed by co-transfection of AIM2
with mCherry-tagged ASCFL, ASCPYD, ASCD130R or ASCD134R in
HEK293T cells. Co-localization and co-immunoprecipitation
assays demonstrated that GFP-ASCCARD was only able to interact
with WT ASC and not with ASCD130R or ASCD134R, confirming
that the two mutations blocked ASCCARD–ASCCARD interaction
(Supplementary Fig. 2g,h).
If the ASCCARD organizes ASC filaments into dense specks,
we speculated that increasing levels of ASCCARD mutants would
disrupt specks formed by WT ASC, resulting in larger but less
dense ASC specks. Therefore, we retrovirally transduced various
ratios of mCherry-tagged WT and mCherry-tagged ASCD130R
into primary WT C57BL/6 macrophages (containing endogenous
ASC) and measured median speck size on the activation of AIM2
by poly(dA:dT) transfection or NLRP3 by Nigericin, a pore-
forming toxin35. Indeed, increasing levels of ASCD130R resulted in
a significant increase in ASC speck size (Fig. 2e,f). As expected,
microscopy analysis of these large ASC specks showed that they
were also less dense and had a filamentous nature (Fig. 2g). Taken
together, these results support a model in which the ASC speck
observed in WT cells is composed of individual ASC filaments
that are formed via their PYDs and cross-linked to each other via
their CARDs (Supplementary Fig. 3a).
NLRC4 oligomerizes ASC via a bridging ASC molecule. Most
inflammasome-forming receptors contain a PYD and initiate
ASC filaments directly by homotypic PYD–PYD interactions.
Notable exceptions are NLRC4 and mouse Nlrp1b, which contain
a CARD and thus might recruit and activate caspase-1
directly42,43. Nevertheless, ASC promotes caspase-1 processing
and efficient IL-1b/-18 release after NLRC4 and Nlrp1b
activation26,44. ASC specks can be observed after NLRC4
activation, but how CARD-containing receptors initiate
oligomerization of ASC is unknown. Theoretically, NLRC4
could initiate ASC oligomerization either by (i) NLRC4CARD–
ASCCARD interaction and ASCCARD oligomerization, (ii) hetero-
typic interaction between related death-fold domains, that is,
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Figure 1 | Both domains of ASC are required for signalling. (a) Schematic
representation of the domain organization of fluorophore-tagged (mCherry
or enhanced GFP (eGFP)) WT ASC (ASCFL), ASCPYD and ASCCARD
constructs. (b) Release of LDH (assessing cell death) and IL-1b from
LPS-primed immortalized WT, Asc / or Asc / BMDMs expressing
ASCFL, ASCPYD or ASCCARD 3 h after poly(dA:dT) transfection (1mgml 1).
(c) Representative images of cell lines from (b) 3 h after poly(dA:dT)
transfection (1 mgml 1) or 1 h after ATP treatment (5mM). DNA (blue,
Hoechst), ASCFL or ASCPYD (red) and ASCCARD (green). Scale bars,
10mm. Data (b,c) are representative of three independent experiments.
Graphs show the mean and s.d. from quadruplicate wells. See also
Supplementary Fig. 1.
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by a non-canonical NLRC4CARD–ASCPYD interaction or (iii) via
bridging ASC molecules that would be linked with NLRC4 via
CARD–CARD interactions and provide their free PYDs as seeds
for ASCPYD filament formation. To determine which domain of
ASC was necessary for ASC speck formation after NLRC4
activation, we infected the above described cell lines harbouring
the single domains of ASC with log-phase Salmonella enterica
serovar Typhimurium SL1344 (Salmonella Typhimurium), a
robust activator of NLRC4 (refs 45,46). Consistent with
published reports24,27,47, immortalized Asc / BMDMs still
induced cell death, whereas efficient IL-1b processing and release
required ASC (Fig. 3a). Expression of ASCFL in Asc / cells
restored IL-1b release, but neither the ASCPYD nor ASCCARD
alone were able to functionally restore inflammasome activation
(Fig. 3a). We next analysed whether the ASCPYD or ASCCARD
would form specks or filaments after NLRC4 activation by
microscopy. Although ASCFL formed specks, ASCPYD alone did
not initiate filaments following activation of NLRC4 (Fig. 3b,c),
which was in contrast to what we had observed for PYD-
containing receptors (Fig. 1c). In addition, cells expressing
ASCCARD alone did not form any specks or macromolecular
filaments, again suggesting that the ASCCARD in the endogenous
setting is not able to form filaments (Fig. 3b,c). These results
exclude the possibilities that ASC specks form via CARD
oligomerization after NLRC4 activation, or that a heterotypic
NLRC4CARD–ASCPYD interaction initiates ASC filament
formation. Instead, they suggest that one or several bridging
molecules of ASC are required to initiate ASC filament formation
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Figure 2 | The CARD of ASC condenses PYD filaments into the speck. (a) Structural model of the mouse ASCCARD based on the human homologue
(PDB 2KN6 (ref. 67)). The structure is shown in ribbon (left) and electrostatic surface representation (right, blue, positive charge; red, negative charge).
Residues D130 and D134, involved in the interaction with pro-caspase-1, are highlighted31. (b) Release of LDH and IL-1b from LPS-primed immortalized
Asc / BMDMs and Asc /BMDMs expressing ASCFL, ASCD130R or ASCD134R 3 h after poly(dA:dT) transfection (1 mgml 1). (c,d) Representative
images of cell lines from (b) 3 h after poly(dA:dT) transfection (1mg ml 1) (c) or 1 h after ATP treatment (5mM) (d). DNA was stained with Hoechst
(blue) and ASC (red). Scale bars, 10mm. (e,f) Measurement of the ASC speck diameter in primary C57BL/6 BMDMs transduced with the indicated ratio of
mCherry-tagged ASCFL or ASCD130R and transfected with poly(dA:dT) (3 h at 1 mgml 1 (e)) or treated with nigericin (1 h, 20 mM (f)) after LPS priming.
(g) Representative images from e. DNA was stained with Hoechst (blue) and ASC (red). Scale bars, 5 mm. Data are representative of three (b–d)
independent experiments. Graphs show the mean and s.d. from quadruplicate wells (b) or triplicate coverslips (e,f). The numbers of specks measured were
99, 92, 104, 94 and 108 in (e) and 149, 134, 85, 98 and 95 in (f). *Po0.05, **Po0.01 and ***Po0.001 (one-way analysis of variance). See also
Supplementary Figs 2 and 3.
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after NLRC4 activation, and that in these conditions ASC
oligomerization into filaments and specks also proceeds via the
ASCPYD.
We also examined cells expressing ASCD130R and ASCD134R
mutants, which are defective for CARD–CARD interactions
(Supplementary Fig. 2g,h (ref. 31)). As expected, expression of
these mutants in Asc / macrophages did not complement the
release of mature IL-1b after NLRC4 activation (Fig. 3d).
Furthermore, we did not observe the formation of filaments or
specks in cells expressing ASCD130R or ASCD134R (Fig. 3e),
confirming the requirement for a functional ASCCARD for ASC
oligomerization by NLRC4. Finally, we also tested our notion that
the ASCCARD is required to condense ASC filaments into a speck
in the context of NLRC4 activation. Primary WT C57BL/6
BMDMs (containing endogenous ASC, thus enabling initiation of
ASC oligomerization) were retrovirally transduced with varying
ratios of mCherry-tagged ASCFL or ASCD130R and the speck
diameter was measured on S. Typhimurium infection (Fig. 3f).
The increase in speck size concurring with increasing concentra-
tions of the ASCD130R mutant indicated that also in the NLRC4
inflammasome the ASCCARD condenses the ASC filaments
into the speck. In conclusion, our results suggested a triple
functional role for ASCCARD in the NLRC4 inflammasome: (1)
mediating the interaction with pro-caspase-1 (refs 17,31), (2)
condensing ASCPYD filaments into the speck and (3) initiating
ASC oligomerization through bridging ASC molecules
(Supplementary Fig. 3b).
Pyroptosis induction is independent of ASC oligomerization.
Having elucidated the general architecture of the ASC speck, we
next investigated whether the ASC speck constitutes the active,
signalling-competent inflammasome. Higher-order signalosomes
were reported for other innate immune signalling pathways
(Toll-like receptors, receptor-interacting serine/threonine-protein
kinase 2 (RIP2K) and MAVS) and could promote signal ampli-
fication and digital all-or-nothing responses48, leading us to
hypothesize that ASC oligomerization and filament formation
might have a similar function for inflammasome signalling.
Within the ASCPYD filaments that form the backbone of ASC
specks in human and murine cells (Supplementary Fig. 4a
(refs 13,15)), individual ASCPYDs interact with other six adjacent
ASCPYDs through three asymmetric interfaces, types I–III
(Fig. 4a). Mutations targeting these interfaces can abrogate
ASC filament formation in vitro or in cell overexpression
systems13,29,49. As these mutations also most probably abrogate
the interaction between the receptorPYD and ASCPYD, and/or
were only tested in an artificial overexpression system, a definite
confirmation that ASC filament formation is required for
inflammasome signalling is still missing50. Identification of
mutations that abrogate ASC oligomerization but leave
ASC–receptor interaction intact allowed us to characterize the
role of ASC filaments in inflammasome signalling. Therefore, we
generated a number of clonal immortalized Asc / macrophage
lines expressing different mCherry-tagged ASC mutants targeting
all three interaction interfaces (Fig. 4a and Supplementary
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Figure 3 | A bridging ASC molecule is required for ASC speck formation after NLRC4 activation. (a) Release of LDH and IL-1b from LPS-primed
immortalized WT, Asc / or Asc / BMDMs expressing ASCFL, ASCPYD or ASCCARD after infection with log-phase WT S. Typhimurium SL1344
(multiplicity of infection (MOI) 10 for 1 h). (b) Quantification of the percentage of cells from a with ASC specks or filaments (collectively referred to as
ASC aggregates). (c) Representative images of cell lines from b. DNA (blue, Hoechst) and ASC (red). Scale bars, 10mm. (d) Release of LDH and IL-1b from
LPS-primed Asc / BMDMs and Asc / BMDMs expressing ASCFL, ASCD130R or ASCD134R after infection with log-phase WT S. Typhimurium SL1344
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and triplicate coverslips in f. The numbers of specks measured were 194, 134, 184, 128 and 141 in f. *Po0.05, **Po0.01 and ***Po0.001 (one-way analysis
of variance). See also Supplementary Fig. 3.
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Fig. 4b–d). Next, we assessed the effects of these mutations on
ASC speck/filament formation on AIM2 activation by poly(dA:dT)
transfection. Mutations targeting interface I (that is, K21A, K26A,
D48N and D51R) completely abrogated the filament formation as
determined by microscopy (Fig. 4b upper panel and
Supplementary Fig. 4e). This is consistent with interface I being
the most extensive interface and required for the propagation of
single layers of the filament13,15. In contrast, mutations in
interfaces II and III displayed a larger variability, ranging from no
defect in ASC speck formation (Y36A, E62A (interface II) or
P40A (interface III)), intermediate phenotypes (M76A (interface
II) or L15A (interface III)) to complete abrogation in ASC speck
formation (Y59A, Q79E, E80R (interface II) or E13R and R41E
(interface III)) (Fig. 4c,d upper panels and Supplementary
Fig. 4e). Taken together, these data suggest that the formation
of ASC specks requires all three interfaces of ASCPYD.
We next tested how these mutations affect downstream
inflammasome signalling by measuring IL-1b secretion
(Fig. 4b–d middle panels) and pyroptosis (Fig. 4b–d lower
panels). In line with the loss of ASC speck formation, interface I
proved to be essential for induction of downstream inflamma-
some signalling (Fig. 4b). Macrophages expressing mutants in
interface III of ASCPYD displayed similar phenotypes as interface
I mutations: the ability to form ASC specks correlated with both
IL-1b secretion and pyroptosis, that is, mutants either lost all
inflammasome signalling (E13R and R41E), were partially
affected (L15A) or not affected at all (P40A) (Fig. 4d). These
results show that interface III is important for induction of
downstream inflammasome signalling, albeit some mutations are
tolerated.
Mutants in interface II displayed a differential signalling
phenotype (Fig. 4c). Although some mutations had no or only a
very small effect on inflammasome signalling (Y36A, E62A and
M76A) or abrogated inflammasome signalling altogether (Q79E),
we identified two mutations (Y59A and E80R) that retained the
ability to induce cell death, while losing the ability to release
mature IL-1b and to form ASC specks in response to AIM2
stimulation (Fig. 4c middle and lower panels, highlighted in grey).
Of note, the ELISA assay displays a higher sensitivity for the
mature form of IL-1b than the pro-form, thus pro-IL-1b, which is
potentially released into the supernatant by pyroptosis, is poorly
detected (Supplementary Fig. 5). To test whether the phenotype
of the different mutants is specific to the AIM2 inflammasome,
we analysed ASC speck formation, secretion of mature IL-1b and
pyroptosis in response to NLRP3 stimulation by ATP treatment.
Asc / macrophages expressing the ASC interface I, II and III
mutants showed the same phenotype for NLRP3 stimulation as
for AIM2 stimulation (Supplementary Fig. 6a–c). Importantly,
also ASCY59A and ASCE80R mutations abrogated speck formation
and IL-1b secretion but still promoted pyroptosis on NLRP3
stimulation (Supplementary Fig. 6b, highlighted in grey). Finally,
we also examined IL-1b release and pyroptosis of macrophages
expressing interface II mutants treated with Clostridium difficile
Toxin B (TcdB). TcdB was recently described to activate the pyrin
inflammasome, which senses modifications of Rho GTPases6.
Again, Asc / macrophages expressing ASCY59A or ASCE80R
were competent for cell death induction but could not efficiently
release IL-1b (Supplementary Fig. 6d, highlighted in grey). In
conclusion, our site-directed mutagenesis approach identified two
mutations, Y59A and E80R, in the inflammasome adaptor ASC
that uncouple pyroptosis from ASC speck formation and cytokine
secretion.
ASC oligomerization mutants maintain receptor interaction.
As cell death was still observed in cells expressing ASCY59A and
ASCE80R, we speculated that the mutant proteins retained the
ability to interact with the PYD of the receptor, but lost the
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ability to oligomerize into ASC filaments. To investigate this,
we reconstituted the AIM2 inflammasome by co-expressing
V5-tagged AIM2 with ASCFL or the ASCK21A, ASCY59A or
ASCE80R mutants in HEK293T cells. AIM2 interactors were then
immunoprecipitated using an anti-V5 antibody and analysed by
western blotting (Fig. 5a). Consistent with our notion, ASCY59A
and ASCE80R retained the ability to interact with AIM2, similar to
WT ASC. In contrast, ASCK21A did not interact with AIM2,
possibly explaining the clear-cut phenotypes of interface I
mutants (Fig. 4b and Supplementary Fig. 6b).
Given that ASCY59A and ASCE80R mutants still interacted with
the receptor (Fig. 5a), but did not form any ASC filaments/specks
(Fig. 4c and Supplementary Fig. 4e), we speculated that the
mutations abolished or reduced the ability of ASC to organize
itself into filaments following the recruitment to the activated
receptor. Based on our previous observation that purified
ASCPYD or ASCFL form filaments in vitro15, we established an
assay to monitor the kinetics of this oligomerization process by
dynamic light scattering and analysed the kinetics of filament
formation for WT ASCPYD and the above-mentioned mutants
(Fig. 5b,c and Supplementary Fig. 7a,b). Although WT PYD
rapidly formed well-structured filaments, the K21A mutant was
no longer able to oligomerize correctly and formed unspecific
aggregates (Fig. 5d). Interestingly, E80R also lost the ability to
oligomerize into ordered filaments, whereas the Y59A mutant
formed well-ordered filaments, but at a much slower rate than the
WT protein (Fig. 5b–d and Supplementary Fig. 7a,b). Thus, these
results confirmed that the ASC–receptor interaction and the ASC
filament formation can be uncoupled, and that the ability to
rapidly form filaments/specks strongly correlates with the levels
of cytokine production but not cell death.
Gasdermin-D cleavage is independent of ASC oligomerization.
The observation that even in the absence of ASC oligomerization
inflammasome activation still promotes cell death but not
cytokine release (Fig. 4c, Supplementary Fig. 4e) was reminiscent
of NLRC4 activation in Asc / macrophages24. In the absence
of ASC, NLRC4 interacts with pro-caspase-1 to initiate cell death
but not efficient caspase-1 autoprocessing and cytokine secretion.
We therefore examined to what level ASCY59A and ASCE80R were
able to promote caspase-1 autoprocessing on activation of the
AIM2 inflammasome. In contrast to cells expressing ASCFL,
macrophages expressing the mutant proteins displayed
significantly reduced levels of caspase-1 processing, as
determined by western blotting for the released p20 subunit
(Fig. 6a). Furthermore, caspase-1 autoprocessing correlated with
the amount of released bioactive IL-1b (Figs 4c and 6a), but not
with the induction of cell death (Fig. 4c) and the release of the
danger signal high mobility group box 1 (HMGB1) into the cell
supernatants (Fig. 6a), an alternative marker for cell lysis during
inflammasome activation51. Similarly, results were obtained on
activation of the NLRP3 inflammasome (Supplementary Fig. 8a).
To exclude the possibility that the observed cell death is induced
through caspase-1-independent pathways, we knocked out Casp1
by CRISPR-Cas9-mediated gene targeting52,53 in the cell lines
expressing ASCFL, ASCY59A or ASCE80R. Western blotting for
pro-caspase-1 confirmed successful targeting (Supplementary
Fig. 8b). Casp1 deficiency significantly abrogated pyroptosis
induction in cells expressing ASCFL, ASCY59A or ASCE80R
(Fig. 6b), thus confirming that the cell death observed in the
parental cell lines was caspase-1 dependent. Taken together, these
data confirm that caspase-1 processing is not a prerequisite
for induction of cell death, expanding previous findings from
CARD-containing inflammasome receptors24 to PYD-containing
receptors.
Recent reports showed that a major substrate of caspase-1
responsible for pyroptosis is gasdermin-D, and that Gsdmd-
deficiency abrogates pyroptosis11,12. Caspase-1 cleaves
full-length gasdermin-D, whereby the active N-terminal
fragment (gasdermin-DNterm) is generated (Supplementary
Fig. 8c,d), which induces pyroptotic cell death11,12.
Consistently, CRISPR-Casp9-mediated Gsdmd knockout
(Supplementary Fig. 8e) reduced cell death significantly in
response to AIM2 and NLRP3 activation (Supplementary
Fig. 8f,g). As ASCY59A and ASCE80R mutants induced cell
death, we speculated that gasdermin-D is still processed in cells
expressing these mutant forms of ASC. Indeed, although
gasdermin-D was not processed in Asc / macrophages on
stimulation of AIM2 or NLRP3, we observed gasdermin-D
processing to its 30 kDa gasdermin-DNterm fragment in Asc /
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Figure 5 | ASC–receptor interaction and ASC filament formation
can be uncoupled genetically. (a) Western blot analysis of the interaction
of AIM2 with ASCFL or the indicated ASC mutants. AIM2-V5 was
immunoprecipitated from lysates of HEK293T cells co-transfected with
AIM2-V5 and the indicated ASC mutants. Co-immunoprecipitating proteins
were identified using anti-ASC and anti-V5. *Immunoglobulin heavy chain.
Results shown are representative from two independent experiments.
(b) Filament formation of WT ASCPYD and its single amino-acid variants
K21A, Y59A and E80R in vitro monitored by dynamic light scattering.
Normalized growth signals (IN) are reported as a function of time for one
representative experiment for each variant (dots). Best fits to single
exponential functions are shown with solid lines. (c) Kinetic rate constants
kF of filament formation obtained from three independent experiments.
(d) Representative negative-stained TEM micrographs of filament formed
by ASCPYD and its variants after 350min of incubation at physiological pH
condition. Scale bars, 200nm. See also Supplementary Figs 7 and 9.
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macrophages expressing ASCFL, ASCY59A and ASCE80R (Fig. 6c
and Supplementary Fig. 8h). Furthermore, processing of
gasdermin-D on AIM2 stimulation is dependent on caspase-1
in cells harbouring oligomerization-deficient ASC mutants, as
Casp1 deficiency abrogated gasdermin-D cleavage (Fig. 6c). These
results indicated that gasdermin-DNterm causes the cell death
observed in these mutations. As significant levels of cell death can
be observed in Asc-deficient macrophages after NLRC4
activation24, but caspase-1 processing is reduced below
detection levels, we next determined whether gasdermin-D is
processed under these conditions. Indeed, we found that the
induction of cell death in S. Typhimurium-infected WT, Asc /
and Casp1 / /Casp11 / macrophages (Fig. 6d) correlated
with detectable levels of processed gasdermin-D (Fig. 6e).
Furthermore, CRISPR-Cas9-mediated Gsdmd knockout
confirmed that gasdermin-D played an essential role in
inducing pyroptosis during S. Typhimurium infections
(Supplementary Fig. 8i). Taken together, these results confirm
that even the smallest amounts of active caspase-1, as judged by
the amount of processed caspase-1 p20 subunits, are sufficient to
efficiently process gasdermin-D and trigger gasdermin-D-induced
cell death. On the other hand, large amounts of processed, active
caspase-1 are required to produce detectable amounts of mature,
bioactive IL-1b as seen by the direct correlation of the level of
caspase-1 processing with the levels of cytokine release.
Importantly, the ability of ASC to form filaments and ASC
specks correlates with caspase-1 activation and cytokine
processing, thus supporting a model in which the rapid
formation of ASC filaments acts as a signal amplification
mechanism for inflammasomes, generating a multitude of
caspase-1 activation sites and thus enabling the cells to rapidly
mature IL-1b before the onset of pyroptosis.
Discussion
The formation of higher-order signalling machineries, signalo-
somes, for transmission of receptor activation information to
cellular responses is an emerging theme in signal transduction48.
It is particularly important in innate immune signalling, where
the signal generated by a few ligand–receptor interactions needs
to trigger an appropriate cellular response. Formation of
oligomers has been reported for different signalling adaptors,
for example, B-cell lymphoma/leukemia 10 (Bcl10) or MAVS
filaments, the Myddosome36,54,55 and others. However, the
archetypical supramolecular assembly formed during
inflammasome activation, the ASC speck, has remained
relatively poorly understood. Here we present evidence that the
formation of ASC speck by oligomerization of the inflammasome
adaptor protein ASC acts as a signal amplification mechanism for
inflammasomes (Fig. 7), as the rapid formation of ASCPYD
filaments that expose ASCCARD on their surface creates a
multitude of pro-caspase-1 recruitment and activation sites. We
speculate that such a system might therefore be able to detect the
smallest amounts of PAMPs in the host cell cytosol, as recent
reports have shown that a single ligand molecule (flagellin, PrgJ)
is sufficient to initiate assembly of a NLR family, apoptosis
inhibitory protein (NAIP) and 10–12 NLRC4 proteins into a
wheel-shaped receptor oligomer that acts as seed for ASC
oligomerization39,56.
Our result reveals that this signal amplification mechanism
only applies to cytokine maturation, whereas gasdermin-D-
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Figure 6 | Caspase-1 but not gasdermin-D processing depends on ASC oligomerization. (a) Western blot analysis for cleaved caspase-1 p20, IL-1b p17,
and HMGB-1 in cell supernatants (SN) and pro-caspase-1, pro-IL-1b and HMGB-1 in cell lysates (lys) of LPS-primed immortalized Asc / BMDMs or
Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R 3 h after poly(dA:dT) transfection (1mgml 1). (b) Release of LDH from LPS-primed
immortalized Asc / BMDMs or Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R, or derived Casp1 knockouts 3 h after poly(dA:dT) transfection
(1mgml 1). (c) Western blot analysis for processing of full-length gasdermin-D (GSDMDFL) into the active N-terminal fragment (GSDMDN-term) in
combined lysates and supernatants (lys þ SN) of LPS-primed immortalized Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R, or derived Casp1
knockouts 3 h after poly(dA:dT) transfection (1 mgml 1). Arrowhead, gasdermin-DNterm p30; *a cross-reacting band. (d) Release of LDH from LPS-primed
primary C57BL/6 WT (WT), Casp1 //Casp11 / or Asc / BMDMs infected with S. Typhimurium (multiplicity of infection (MOI)¼ 10, 1 h). (e)
Western blot analysis for processing of full-length gasdermin-D (GSDMDFL) into the active N-terminal fragment (GSDMDN-term) in combined lysates and
supernatants (lysþ SN) of LPS-primed primary C57BL/6 WT (WT), Casp1 //Casp11 / or Asc / BMDMs infected with S. Typhimurium (MOI¼ 10,
1 h) or left uninfected. Arrowhead, gasdermin-DNterm p30; *a cross-reacting band; ** a S. Typhimurium-specific cross-reactive band. See also
Supplementary Figs 8 and 9.
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induced pyroptotic cell death could be observed even in the
absence of ASC oligomerization. Why would cells need to amplify
the receptor-generated signal to process IL-1b/-18? We speculate
that a cell will inevitably progress towards pyroptosis, once a few
molecules of caspase-1 have been activated, given the rapid
kinetics by which gasdermin-D is processed57 and the strong
toxicity of the gasdermin-DNterm fragment11,12. This fate leaves a
limited time window to mature the pro-forms of IL-1b/-18 to
their bioactive form. As processing of IL-1b/-18 occurs with slow
kinetics, increasing the amount of active caspase-1 is a means to
generate large amounts of bioactive IL-1b/-18 in the available
time window. Consistent with this notion we have observed that
gasdermin-D processing does not correlate with the overall level
of active caspase-1. Furthermore, pyroptosis has been observed to
occur within 30–60min in stimulated cells, whereas ASC speck
formation was reported to proceed much faster23,58, with all
cytosolic ASC being incorporated into a speck in o3min20,59.
Thus, ASC speck formation might serve to activate sufficient
amounts of caspase-1 to generate enough bioactive cytokines
before the cell lyses and releases its intracellular content,
including proteolytically matured cytokines.
Although recent studies revealed that ASC specks are
filamentous in nature22,23, consistent with recently reported
structures of human and murine ASCPYD filaments13,15, it was so
far unknown how these filaments assemble into a speck. Our
mutagenesis studies indicates that the clustering of ASCPYD
filaments and finally their condensation into a dense ASC speck
structure is mediated by the ASCCARD, which, as we have
shown15, is exposed on the surface of the ASCPYD filament. These
results have uncovered a function for the ASCCARD in ASC speck
formation, beyond its role as adaptor domain between receptor
and caspase-1. How ASCCARDs condense ASCPYD filaments is
unknown, but it can be assumed that either dimeric interactions
between ASCCARDs or limited oligomerization of ASCCARD from
different filaments could build lattices interconnecting the
ASCPYD filaments. Interestingly, the same residues in ASCCARD
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that are required for ASC–pro-caspase-1 interaction are also
needed for ASC speck formation. Notably, it has previously been
shown that phosphorylation of the ASCCARD at Y144/Y146 is not
only required for caspase-1 activation, but also for ASC speck
formation60,61 Our model of the ASC speck, which includes
interactions between the ASCCARD domains, now provides a
structural rationale for these data. To which extent ASC filaments
are still formed in the absence of ASCCARD phosphorylation
remains to be determined.
Recently, a unified assembly mechanism was proposed for the
PYD-containing receptors AIM2 and NLRP3: the receptors
nucleate clusters of ASC through PYD–PYD interactions, which
in turn nucleate caspase-1 filaments13. In analogy, it was
proposed that the CARD-containing receptor NLRC4 directly
nucleates caspase-1 filaments13,39, as in theory CARD-containing
receptors do not require ASC for caspase-1 recruitment.
Although direct recruitment of pro-caspase-1 to NLRC4 might
indeed happen in Asc-deficient cells as we hypothesized before24,
it does not seem to efficiently activate caspase-1, because we and
others have reported that caspase-1 processing into its p20/p10
subunits and the levels of released mature cytokines are reduced.
Furthermore, a large number of ASC specks can be observed in
WT cells on NLRC4 activation24–28, indicating that ASC
nevertheless plays an important role in NLRC4 signalling. Our
results now indicate that the ASCCARD lacks the ability to form
higher-order oligomers at physiological concentrations, and that
even on NLRC4 activation ASC speck formation relies on the
ASCPYD. Our data thus support a model in which CARD-
containing receptors initiate ASC speck formation with the help
of ASC bridging molecules, and that the PYDs of these ASC
molecules nucleates an ASCPYD filament. Thus, the ASCCARD can
have a triple function in inflammasome signalling on CARD-
receptor activation.
In conclusion, our study gives insights into the architecture of
the ASC speck and the mechanism by which ASC filaments
assemble this structure. Furthermore, we provide experimental
evidence that ASC filament formation serves as an amplification
mechanism in inflammasome signalling, and that this amplifica-
tion serves to generate sufficient mature cytokines before the
onset of pyroptotic cell death. Nevertheless, important questions
remain; the higher-resolution structure of the activated NLRC4
receptor has been recently reported39,56, yet how exactly such
receptor complexes with C10–C12 stoichiometry initiate the
3-start ASCPYD filaments is still unknown. Furthermore, the
structure of the whole ASC speck assembly, including receptor,
ASC and caspase-1, is still lacking and it remains unknown
whether other proteins participate in its formation. Finally,
additional theoretical and experimental approaches will be
necessary to understand if and how ASC speck formation
might impart threshold responses, reduce biological noise and
control temporal and spatial control of inflammasome signalling.
Methods
Cell culture. Immortalized BMDM cell lines were generated from bone marrow
using infection with a v-myc/v-raf-expressing J2 retrovirus24,62. WT and Asc /
immortalized murine BMDMs were cultured in DMEM (Sigma) supplemented
with 10% FCS (Bioconcept) and 10% 3T3-MCSF supernatant, and incubated at
37 C with 5% CO2.
Generation of monoclonal cell lines with mutations in ASC. Murine AscFL and
AscPYD were cloned with a carboxy-terminal mCherry tag and AscCARD with an
N-terminal enhanced GFP tag into V48, a derivative of the replication-defective
murine stem cell retroviral construct pMSCV2.2 (excision of the IRES-GFP by
EcoRI digestion, gift from Thomas Henry). Mutations were introduced by SOE
PCR using appropriate oligonucleotides (Supplementary Table 1) and cloned into
V48. GP2 packaging cells were transfected with the individual vectors (9 mg per
1.5 106 cells) and the lentviral envelope vector VSV-G (Addgene, 6 mg per
1.5 106 cells), and the retroviral particles were used to transduce Asc /
iBMDMs (106 cells). Seven days later, the transduced iBMDMs were sorted into
single cells based on the mCherry or enhanced GFP expression (FACS) and
grown up to clonal cell lines. Up to ten clones of each cell line were tested for
inflammasome activation and the level of ASC expression was assessed by western
blotting and a representative clone was selected for further analysis.
Retroviral transduction of primary BMDMs. For transduction of primary bone
marrow cells, retroviral particles were generated in Phoenix-Eco packaging cells
and used to transduce WT C57BL/6 bone marrow cells after 48 and 72 h of culture
in medium with 10% 3T3-MCSF supernatant. Inflammasome stimulation was
performed 4 days after the first transduction24.
Inflammasome stimulation. Immortalized BMDMs (seeded at 250 000 cells
per ml in 96-well plates) were primed for 4 h with 100 ngml 1 LPS O55:B5
(Invivogen). The NLRP3 inflammasome was triggered by addition of 5mM
extracellular ATP (Sigma-Aldrich) for 60min. The AIM2 inflammasome was
triggered by transfection of 1 mgml 1 of the synthetic DNA analogue poly(dA:dT)
(Invivogen) using Lipofectamine 2000 (Invitrogen), according to the manu-
facturer’s protocol, in OptiMEM (Gibco) for 3 h. The NLRC4 inflammasome
was triggered by infection of the cells with S. enterica serovar Typhimurium
SL1344 at a multiplicity of infection of 10. The infection was synchronized by
centrifugation and continued for 60min. The pyrin inflammasome was triggered
by addition of 1 mgml 1 (final concentration) of C. difficile toxin B (CdtB, Enzo
Biotech) for 2.5 h.
Cell death and IL-1b release measurements. IL-1b release was measured by
ELISA (eBiosciences). Cell death was quantified by measuring LDH release
using the LDH Cytotoxicity detection kit (TaKaRa Clontech). To normalize
for spontaneous cell lysis, the percentage of cell death was calculated as follows:
[(LDH sample) (LDH negative control)]/[(LDH positive control) (LDH
negative control)] 100.
Imaging and quantification of ASC speck formation. Cells were seeded on
coverslips (150 000 cells per coverslip) and treated as described above with the
addition of 25mM Z-VAD-fmk (Bachem) to prevent detachment of pyroptotic
cells and therefore loss of cells with ASC specks. Coverslips were fixed with 4%
paraformaldehyde (PFA) (15min, 37 C, Alfa Aesar) and washed with PBS. Nuclei
were stained with Hoechst 33342 (Life Technologies) for 10min and the slides
mounted using Vectashield (Vector Laboratories). For quantifications of ASC
aggregates (specks or filaments), ten random regions of interest were imaged at
 20 magnification (Leica DMI3000B inverted fluorescence microscope, HCX PL
FLUOTAR objective, Leica DFC3000G camera and LAS AF Version 3 software)
and the number of ASC aggregates and cells were counted. For representative
images, the slides were imaged at  63 magnification (Leica point scanning
confocal ‘SP8’, HC PL APO CS2  63 objective, Leica AF software version 3).
For measurements of speck sizes, random regions of interest were images at
 63 magnification (Leica point scanning confocal ‘SP8’) and the largest diameters
of individual specks were measured using Fiji63.
Western blotting. For western blotting of supernatant and lysate samples, cells
were seeded at 106 cells per well in six-well plates and treated as described above.
Supernatants were precipitated with 10% trichloracetic acid, precipitates washed
with acetone and resuspended in 40 ml 1 SDS–PAGE sample buffer and boiled at
95 C for 10min. Cells were lysed with 200ml 1 RIPA (50mM Tris-HCl pH 7.5,
150mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, 1 protease
inhibitor cocktail (Roche)) for 30min on ice. Lysates were re-suspended in
5 SDS–PAGE sample buffer and boiled at 95 C for 10min64. For combined
supernatant and lysates, samples were prepared as above, but supernatant
precipitates were resuspended in lysate samples. Samples were run on 14%
(supernatants or lysates) or 12% (combined SNþ lysates) acrylamide gels (1 h,
170V, 40mA per gel), transferred to polyvinylidene difluoride membranes (1 h,
100V constant), blocked in 5% milk in Tris-buffered salineþTween-20 (TBS-T)
and incubated with primary antibodies in 5% BSA–TBS-T for 16 h at 4 C or 2 h at
room temperature with agitation. Secondary antibodies were diluted 1:5,000 in 5%
milk–TBS-T and incubated for 1 h at room temperature. The membranes were
developed using either LumiGLO (KPL) or LumiGLO Reserve (KPL). The
following antibodies and dilutions were used: rat anti-Caspase-1 p20 (Genentech,
1:1,000; Supplementary Figs 1b,d and 2c,d) or mouse anti-Caspase 1 p20 (1:4,000,
AG20B-0042, AdipoGen; Fig. 6a and Supplementary Fig. 8a), rat anti-ASC
(Genentech, 1:2,000; Fig. 5a and Supplementary Fig. 2a,h) or rabbit anti-ASC
(1:1,000, AG25B-006, Adipogen, all other figures), rabbit anti-IL-18 (5180R-100,
Biovision, 1:1,000), goat anti-IL-1b (AF-401-NA, R&D, 1:1,000), mouse anti-GFP
(632381, Clontech, 1:1,000), mouse anti-mCherry (ab125096, Abcam, 1:1,000),
mouse anti-V5 (R960-25, Invitrogen, 1:1,000), rabbit anti-HMGB1 (GTX-101277,
Genetex, 1:1,000), mouse anti-gasdermin-D (GSDMDC1 (A-7), Santa Cruz
Biotechnology, 1:1,000; Supplementary Fig. 7), rabbit anti-gasdermin-D (1:2,000,
G7422, Sigma, all other figures) and mouse anti-b-actin (A1987, Sigma, 1:1,000).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11929
10 NATURE COMMUNICATIONS | 7:11929 | DOI: 10.1038/ncomms11929 | www.nature.com/naturecommunications
Co-immunoprecipitation. Co-immunoprecipitation was done according to a
modified protocol published previously49. For assessment of ASC/AIM2
interactions, 3 800,000 HEK293T cells were transfected with 2 mg per
well AIM2-V5 and ASC-mCherry (ASCFL, ASCK21A, ASCY59A or ASCE80R)
encoding plasmids at a ratio of 1:4 using linear polyethylenimine (PEI,
Polysciences) at a ratio DNA:PEI of 1:4 (refs 65,66). Twenty-four hours after
transfection, the cells were washed twice with ice-cold 1 PBS and lysed using
HEK lysis buffer (20mM HEPES pH 7.4, 10mM KCl, 1mM EDTA, 0.1mM
phenylmethylsulfonyl fluoride, 1mM Na3VO4, 5mM NaF, 0.5 % Nonidet P-40 and
1 protease inhibitor cocktail (Roche)). Lysates were sonicated for 5 7 s before
removing debris and non-lysed cells by centrifugation (10,000 g, 15min, 4 C). The
samples were incubated with 1 mg mouse anti-V5 antibody (R960-25, Invitrogen)
or a control antibody (mouse anti-GFP, 632381, Clontech) with agitation for 16 h
at 4 C. For assessment of ASCCARD/ASCCARD interactions, 3 800 000 HEK293T
cells were transfected with 1 mg per well ASC-mCherry (ASCFL, ASCPYD,
ASCD130R or ASCD134R), 1 mg per well ASCCARD-GFP and 0.2 mg AIM2-V5, to
initiate ASC/ASC interactions using linear PEI. Forty hours after transfection, the
cells were washed, lysed and sonicated as described above. The samples were then
incubated with 1 mg mouse anti-mCherry antibody (ab125096, Abcam) or a control
antibody (mouse anti-HA, MMS-101R-200, Covance). The samples were then
incubated with agitation for 2 h at 4 C with 25 ml Pierce Protein A Plus Agarose
bead slurry (22810, Thermo Scientific). Beads were washed three times with lysis
buffer (centrifugation 1min 1,000 g, 4 C), resuspended in 2 SDS–PAGE sample
buffer (30 ml) and boiled at 95 C, before analysing the eluted proteins by western
blotting as described above.
CRISPR-Cas9-mediated Caspase1 and Gasdermin-D knockout. Two guide
RNAs52 targeting exon 4 of Casp1 (50-gagggcaagacgtgtacgag-30 and 50-cgagtgg
ttgtattcattat-30) and one guide RNA targeting exon 2 of Gsdmd (50-ggtca
agaatgtgatcaagg-30) were cloned into lentiCRISPRv2 harbouring a puromycin
resistance cassette (Addgene53). These constructs were transfected into HEK293T
cells using PEI (as described above) together with the lentiviral packaging vector
PsPax2 (Addgene) and the lentviral envelope vector VSV-G (Addgene). Sixteen
hours after transfection, medium was exchanged with macrophage medium and
incubated at 37 C for 2 days to produce lentiviral particles. The lentiviral particles
were used to transfect the immortalized macrophage cell lines (800,000 cells per
well in 6-well plates) using polybrene (Merck) to favour virus attachment.
Two days after viral transduction, the macrophages were expanded. Attached
macrophages were then treated with 10 mgml 1 puromycin (Gibco) for 6 days to
select for successful lentiviral transduction. After puromycin selection, the cells
were tested for successful knockout by western blotting.
Expression and purification of ASCPYD. The ASCPYD (residues 1–91) was cloned
with a C-terminal His6 tag into the pET28a vector under the control of a T7
promoter. Protein expression was induced by isopropyl-b-D-thiogalactopyranosid
addition in BL21(DE3) Escherichia coli at an OD600 of 0.8 for 4 h at 37 C. Bacteria
were harvested by centrifugation and resuspended in 50mM phosphate buffer pH
7.5, 300mM NaCl, with Complete protease inhibitor (Roche).
Resuspended bacteria were incubated for 1 h at room temperature with DNase I,
sonicated on ice and centrifuged at 20,000 g at 4 C for 30min. The pellet, including
ASCPYD-containing inclusion bodies, was solubilized in 50mM phosphate buffer
pH 7.5, 300mM NaCl, 6M guanidinium hydrochloride and centrifuged at 20,000 g
at 4 C for 30min. The supernatant was incubated for 2 h at room temperature
with pre-equilibrated Ni-NTA affinity resin (Thermo Scientific) and then passed
through a plastic body column for gravity flow purification. The column was
washed with 20 column volumes of solubilization buffer containing 20mM
imidazole and eluted with 3 column volumes of solubilization buffer with 500mM
imidazole. The pH of the elution fraction was decreased to 3.8 and dialysed against
50mM glycine buffer pH 3.8, 150mM NaCl. The protein was further purified
on a pre-equilibrated Superdex 75 gel filtration column (GE Healthcare). This
gel-filtration step removed traces of pre-existing aggregates and yielded highly
pure, monomeric soluble form of ASCPYD. Samples were either used immediately
or stored after flash-freezing in small aliquots in liquid N2.
Measurements of ASCPYD filament formation kinetics in vitro. Immediately
before the experiments, samples of monomeric soluble ASCPYD were centrifuged at
20,000 g at 4 C for 30min and filtered with 0.1 mM filter (Millipore). The protein
concentration was adjusted to 25 mM by dilution from a higher-concentrated stock
solution. Filament formation was triggered by rapid dilution to neutral pH.
Thereby, 70 ml of monomeric ASCPYD was mixed with 0.45 ml of 2.75M NaOH
solution to a reach the pH of 7.5. The solution was mixed at room temperature by
careful pipetting, to avoid introduction of air bubbles, and immediately transferred
to a quartz cuvette with 1 cm path length. Between runs, cuvettes were carefully
cleaned with 1M Hellmanex solution (Sigma-Aldrich) to avoid cross-seeding
effects between sequential measurements. Filament growth was monitored by
dynamic light scattering with a Malvern Zetasizer Nano ZS series instrument. The
laser focal spot was positioned in the middle of the cuvette and maintained fixed
for all the measurements. To maximize the intensity of the scattered light, the
minimal attenuation level was used. Data were acquired in 60 s intervals by
averaging three runs of 20 s, until a total time of 350min. Afterwards, the protein
solution was blotted on EM grids, negatively stained and imaged with transmission
electron microscopy to visualize filament formation.
Data analysis. Filament growth was modelled assuming pseudo-first-order
kinetics where the filament propagation step occurs by the addition of monomers
to the initial growth centre. The time-dependent growth signal I was fitted
independently for each measurement by a single exponential function,
I tð Þ ¼ I1 1 e  kF tð Þ
 
where IN corresponds to the signal at time t and at infinitive time, respectively, and
kF is the first-order rate constant. Fits were done with nonlinear least-square
minimization.
Data availability. The data that support the findings of this study are available
from the corresponding author upon request.
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